← All themes

GLP-1 & Obesity

GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.

92 stocks

Obesity Second-Order Effects

#	Name	Funds holding	Growth	Growth %	Fund value
1	1 Pfizer PFE $169B	2,676	0	0%	$133B
2	2 Amgen AMGN $234B	2,218	-3	-0.1%	$109B
3	3 Eli Lilly LLY $1.12T	1,949	+62	+3%	$148B
4	4 Becton Dickinson BDX $52.2B	1,522	-17	-1%	$59.8B
5	5 McKesson MCK $117B	970	+8	+0.8%	$26.9B
6	6 Regeneron Pharmaceuticals REGN $81.4B	924	+20	+2%	$42.3B
7	7 AstraZeneca AZN $257B	757	-31	-4%	$20.5B
8	8 Conagra Brands CAG $6.91B	751	+5	+0.7%	$15.2B
9	9 Novo Nordisk NVO $171B	707	+4	+0.6%	$8.87B
10	10 ResMed RMD $33.6B	663	-1	-0.2%	$19.2B
11	11 Lamb Weston LW $7.38B	619	+17	+3%	$9.6B
12	12 West Pharmaceutical WST $27B	590	-3	-0.5%	$19.3B
13	13 DELISTED CATALENT, INC. CTLT	500	-7	-1%	$17.6B
14	14 DaVita DVA $12B	491	-34	-6%	$10.3B
15	15 Teva Pharmaceutical Industries Limited TEVA $48.4B	451	+1	+0.2%	$6.61B
16	16 Medifast MED $133M	277	+16	+6%	$2.06B
17	17 Accendra Health ACH $18.1M	252	+20	+9%	$2.47B
18	18 Inspire Medical Systems INSP $1.99B	251	+11	+5%	$5.21B
19	19 Herbalife HLF $1.53B	244	-9	-4%	$4.61B
20	20 Opko Health OPK $1.14B	239	0	0%	$817M
21	ARNA 21 DELISTED Arena Pharmaceuticals Inc ARNA	235	-19	-7%	$3.89B
22	22 DELISTED WW International WW	218	+3	+1%	$1.98B
23	TWNK 23 DELISTED Hostess Brands, Inc. Class A Common Stock TWNK	197	+21	+12%	$2.19B
24	24 Fresenius Medical Care FMS $11.8B	167	-12	-7%	$715M
25	25 Tootsie Roll Industries TR $2.87B	166	-15	-8%	$440M